Advancing Research for Neurological Diseases Act of 2015

Access to Better Care Act(H.R.5652) ACE Kids Act (S.298/H.R.546) Advancing NIH Strategic Planning and Representation in Medical Research Act(S.2745) Advancing Research for Neurological Diseases Act(S.849/H.R.292) American Heart Month Resolution(S.Res.365) 21st Century Cures Act(H.R.6) Common Sense Savings Act (H.R.4725) Community Parks Revitalization Act (H.R.201) Community Prevention Grants Congenital Heart Futures Reauthorization Act of 2015(S.2248/H.R.3952) Credit for Caring Act(H.R.4708/S.2759) End of Life Care Legislation End Surprise Billing Act(H.R.3770) Enhancing the Stature and Visibility of Medical Rehabilitation Research at NIH Act(H.R.1631/S.800) Indian Health Service Health Professions Tax Fairness Act (H.R.1842/S.536) Menu Labeling (ACA Section 4205) No Child Left Inside Act(H.R.882/S.492) Physical Activity Recommendations for Americans (H.R.1499/S.1793) Prevention and Public Health Fund (ACA Section 4002) Personal Health Investment Today Act (PHIT) (H.R.1218/ S.2218) Public Lands Service Corps Act (H.R.2167/S.1160) RAISE Family Caregivers Act (S.1719/H.R.3099) Reducing Obesity in Youth Act(S.3194) Health Equity and Accountability Act (H.R.5475)

Client expense: $166,728 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Education, Dept of, Environmental Protection Agency (EPA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office

"The Senate Innovations Initiative," issues related to funding for NIH and FDA, data collection, therapeutic incentives, patient engagement, telehealth, and clinical trials; "H.R. 292/S. 849, The Advancing Research for Neurological Diseases Act," all sections;

Client expense: $50,765 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Access to Better Care Act(H.R.5652) ACE Kids Act (S.298/H.R.546) Advancing NIH Strategic Planning and Representation in Medical Research Act(S.2745) Advancing Research for Neurological Diseases Act(S.849/H.R.292) American Heart Month Resolution(S.Res.365) 21st Century Cures Act(H.R.6) Common Sense Savings Act (H.R.4725) Community Parks Revitalization Act (H.R.201) Community Prevention Grants Congenital Heart Futures Reauthorization Act of 2015(S.2248/H.R.3952) Credit for Caring Act(H.R.4708/S.2759) End of Life Care Legislation End Surprise Billing Act(H.R.3770) Enhancing the Stature and Visibility of Medical Rehabilitation Research at NIH Act(H.R.1631/S.800) Indian Health Service Health Professions Tax Fairness Act (H.R.1842/S.536) Menu Labeling (ACA Section 4205) No Child Left Inside Act(H.R.882/S.492) Physical Activity Recommendations for Americans (H.R.1499/S.1793) Prevention and Public Health Fund (ACA Section 4002) Personal Health Investment Today Act (PHIT) (H.R.1218/ S.2218) Public Lands Service Corps Act (H.R.2167/S.1160) RAISE Family Caregivers Act (S.1719/H.R.3099) Reducing Obesity in Youth Act(S.3194) Health Equity and Accountability Act (H.R.5475)

Client expense: $175,017 · Firm income: Not reported

S. 849 / HR 292: The Advancing Research for Neurological Diseases Act S. 2873 / HR 5395: The Expanding Capacity for Health Outcomes (ECHO) for Act HR 34: 21st Century Cures Act Maintenance/expansion of Graduate Medical Education (GME); NIH funding, concussion related issues.

Client expense: Not reported · Firm income: $196,982

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R.34 - 21st Century Cures Act and issues surrounding biomedical research issues, including NIH and FDA issues, and text of H.R. 292 / S.849 Advancing Research for Neurological Diseases Act S.2704/H.R. 4813 ABLE Act, which creates savings accounts for people with disabilities to save for their care

Client expense: $18,810 · Firm income: Not reported

Government targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE

-H.R. 292/S. 849, support passage of the Advancing Research for Neurological Diseases Act. -H.R. 6, 21st Century Cures Act, support inclusion of H.R. 292/S. 849, support increased funding for the National Institutes of Health and support other provisions that speed the development of effective treatments for people with multiple sclerosis. -H.R. 34, 21st Century Cures Act, support inclusion of H.R. 292/S. 849, support increased funding for the National Institutes of Health and support other provisions that speed the development of effective treatments for people with multiple sclerosis. -H.R. 4762/S. 2689, REGROW Act, express concerns about patient safety and oppose inclusion of current version of bill in the Senate Innovations package. - H.R. 34, 21st Century Cures Act, oppose language that would weaken FDA safety/efficacy standards and support language that maintain FDA safety/efficacy standards and providing a clear pathway to market for cellular products.

Client expense: $105,020 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

-H.R. 292/S. 849, support passage of the Advancing Research for Neurological Diseases Act. -H.R. 6, 21st Century Cures Act, support inclusion of H.R. 292/S. 849, support increased funding for the National Institutes of Health and support other provisions that speed the development of effective treatments for people with multiple sclerosis. -H.R. 34, 21st Century Cures Act, support inclusion of H.R. 292/S. 849, support increased funding for the National Institutes of Health and support other provisions that speed the development of effective treatments for people with multiple sclerosis. -H.R. 1516/S. 1013, support passage of the Ensuring Access to Quality Complex Rehabilitation Technology Act. -H.R. 3229/S. 2196, support passage to protect access to complex rehabilitative technology accessories. -H.R. 3913, Lifespan Respite Care Reauthorization Act, support reauthorization of the Lifespan Respite Care Program.

Client expense: $105,020 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

Mental Health Issues (incl. H.R. 34) General Health care Issues (Medicare/Medicaid) Research, Medical and Scientific Issues H.R. 619/S. 276 The Collaborative Academic Research Efforts (CARE)for Tourette Syndrome Act H.R. 292/S. 849 The Advancing Research for Neurological Disease Act of 2015 H.R. 34 21st Century Cures Act

Client expense: $20,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE

-H.R. 292/S. 849, support passage of the Advancing Research for Neurological Diseases Act. -H.R. 6, 21st Century Cures Act, support inclusion of H.R. 292/S. 849, support increased funding for the National Institutes of Health and support other provisions that speed the development of effective treatments for people with multiple sclerosis. -H.R. 1516/S. 1013, support passage of the Ensuring Access to Quality Complex Rehabilitation Technology Act. -H.R. 3229/S. 2196, support passage to protect access to complex rehabilitative technology accessories. -H.R. 3913, Lifespan Respite Care Reauthorization Act, support reauthorization of the Lifespan Respite Care Program.

Client expense: $90,717 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

-H.R. 292/S. 849, support passage of the Advancing Research for Neurological Diseases Act. -H.R. 6, 21st Century Cures Act, support inclusion of H.R. 292/S. 849, support increased funding for the National Institutes of Health and support other provisions that speed the development of effective treatments for people with multiple sclerosis. -H.R. 4762/S. 2689, express concerns about patient safety and oppose inclusion of current version of bill in the Senate Innovations package

Client expense: $90,717 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

Access to Better Care Act(H.R.5652) ACE Kids Act (S.298/H.R.546) Advancing NIH Strategic Planning and Representation in Medical Research Act(S.2745) Advancing Research for Neurological Diseases Act(S.849/H.R.292) American Heart Month Resolution(S.Res.365) 21st Century Cures Act(H.R.6) Common Sense Savings Act (H.R.4725) Community Parks Revitalization Act (H.R.201) Community Prevention Grants Congenital Heart Futures Reauthorization Act of 2015(S.2248/H.R.3952) Credit for Caring Act(H.R.4708/S.2759) End of Life Care Legislation End Surprise Billing Act(H.R.3770) Enhancing the Stature and Visibility of Medical Rehabilitation Research at NIH Act(H.R.1631/S.800) Indian Health Service Health Professions Tax Fairness Act (H.R.1842/S.536) Menu Labeling (ACA Section 4205) No Child Left Inside Act(H.R.882/S.492) Physical Activity Recommendations for Americans (H.R.1499/S.1793) Prevention and Public Health Fund (ACA Section 4002) Personal Health Investment Today Act (PHIT) (H.R.1218/ S.2218) Public Lands Service Corps Act (H.R.2167/S.1160) RAISE Family Caregivers Act (S.1719/H.R.3099) Reducing Obesity in Youth Act(S.3194) Health Equity and Accountability Act (H.R.5475)

Client expense: $166,728 · Firm income: Not reported

S. 849 / HR 292: The Advancing Research for Neurological Diseases Act S. 2873 / HR 5395: The Expanding Capacity for Health Outcomes (ECHO) for Act S. 2943: National Defense Authorization Act for Fiscal Year 2017, Section 705 S. 2978: Protect Continuing Physician Education and Patient Care Act HR 6: 21st Century Cures Act, Title 1, and Sections 1122, & 3021 HR 6010: Zika Pregnancy and Infant Registry Act of 2016 Maintenance/expansion of Graduate Medical Education (GME); NIH and Zika Funding; concussion related issues.

Client expense: Not reported · Firm income: $170,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 292/S 849 - Advancing Research for Neurological Diseases - to establish a national data collection system. National Institutes of Health Funding Parkinson's Research Program at the Department of Defense

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Access to Better Care Act(H.R.5652) ACE Kids Act (S.298/H.R.546) Advancing NIH Strategic Planning and Representation in Medical Research Act(S.2745) Advancing Research for Neurological Diseases Act(S.849/H.R.292) American Heart Month Resolution(S.Res.365) 21st Century Cures Act(H.R.6) Common Sense Savings Act (H.R.4725) Community Parks Revitalization Act (H.R.201) Community Prevention Grants Congenital Heart Futures Reauthorization Act of 2015(S.2248/H.R.3952) Credit for Caring Act(H.R.4708/S.2759) End of Life Care Legislation End Surprise Billing Act(H.R.3770) Enhancing the Stature and Visibility of Medical Rehabilitation Research at NIH Act(H.R.1631/S.800) Indian Health Service Health Professions Tax Fairness Act (H.R.1842/S.536) Menu Labeling (ACA Section 4205) Meeting with HHS Secretary-Precision Medicine, ACA, Workplace Wellness, and Sodium No Child Left Inside Act(H.R.882/S.492) Physical Activity Recommendations for Americans (H.R.1499/S.1793) Prevention and Public Health Fund (ACA Section 4002) Personal Health Investment Today Act (PHIT) (H.R.1218/ S.2218) Public Lands Service Corps Act (H.R.2167/S.1160) RAISE Family Caregivers Act (S.1719/H.R.3099)

Client expense: $159,620 · Firm income: Not reported

-H.R. 292/S. 849, support passage of the Advancing Research for Neurological Diseases Act. -H.R. 6, 21st Century Cures Act, support inclusion of H.R. 292/S. 849, support increased funding for the National Institutes of Health and support other provisions that speed the development of effective treatments for people with multiple sclerosis. -H.R. 1516/S. 1013, support passage of the Ensuring Access to Quality Complex Rehabilitation Technology Act. -H.R. 3229/S. 2196, support passage to protect access to complex rehabilitative technology accessories. -H.R. 3913, Lifespan Respite Care Reauthorization Act, support reauthorization of the Lifespan Respite Care Program.

Client expense: $88,942 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

-H.R. 292/S. 849, support passage of the Advancing Research for Neurological Diseases Act. -H.R. 6, 21st Century Cures Act, support inclusion of H.R. 292/S. 849, support increased funding for the National Institutes of Health and support other provisions that speed the development of effective treatments for people with multiple sclerosis.

Client expense: $88,942 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

United Spinal supports H.R. 292/S.849 - Advancing Research for Neurological Diseases Act of 2015. This bill will mandate that the Centers for Disease Control and Prevention track the incidence and prevalence of neurological diseases. United Spinal supports S. 800/H.R. 1631 - Enhancing the Stature and Visibility of Medical Rehabilitation Research at the NIH Act which better coordinates rehabilitation and disability research at the NIH. S. 2689 REGROW Act: Met and worked with Sen. Mark Kirks office on language edits to this bill. Participated in a roundtable discussion with Sen. Kirks office along with several other organizations regarding the REGROW Act which sets up an expedited process to get therapies to market. United Spinal, along with the Disability Research and Rehabilitation Coalition, have identified some gaps in the Interagency Committee on Disability Research (ICDR), defining the need for a comprehensive government wide strategic plan for disability, independent living, and rehabilitation research and has shared these comments with appropriate government officials at NIH (including the NIH Research Plan on Rehabilitation) and NIDILRR. As a member of Patients for Biologics Safety and Access, United Spinal is working to educate Congress on the needs for patient protections on pharmaceuticals and better guidance from the Food and Drug Administration on patient use of biosimilars. HR 5009 - Ensuring Patient Access to Critical Breakthrough Products Act of 2016 United Spinal endorses this legislation and signed on to a Congressional House letter in support. This bill provides prompt access to breakthrough diagnostics and treatments. United Spinal Association submitted comments to FDA regarding biologics license application 761024, for ABP 501 (Humira).

Client expense: Not reported · Firm income: $150,000

S. 2508/ HR 4460: Youth Sports Concussion Act HR 6: 21st Century Cures Act, Title 1, and Sections 1122, & 3021 S. 2782/ HR 1859: Ensuring Childrens Access to Specialty Care Act S. 849 / HR 292: The Advancing Research for Neurological Diseases Act S. 2873 / HR 5395: The Expanding Capacity for Health Outcomes (ECHO) for Act HR 5366: Alzheimers Breakthrough Sunshine Act Maintenance/expansion of Graduate Medical Education (GME); NIH Funding; concussion related issues.

Client expense: Not reported · Firm income: $280,000

Government targets: HOUSE OF REPRESENTATIVES, Medicare Payment Advisory Commission (MedPAC), SENATE

"The Senate Innovations Initiative," issues related to funding for NIH and FDA, data collection, therapeutic incentives, patient engagement, telehealth, and clinical trials; "H.R. 292/S. 849, The Advancing Research for Neurological Diseases Act," all sections;

Client expense: $50,765 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

-H.R. 292/S. 849, support passage of the Advancing Research for Neurological Diseases Act. -H.R. 6, 21st Century Cures Act, support inclusion of H.R. 292/S. 849, support increased funding for the National Institutes of Health and support other provisions that speed the development of effective treatments for people with multiple sclerosis. -H.R. 1516/S. 1013, support passage of the Ensuring Access to Quality Complex Rehabilitation Technology Act. -H.R. 3229/S. 2196, support passage to protect access to complex rehabilitative technology accessories. -H.R. 3913, Lifespan Respite Care Reauthorization Act, support reauthorization of the Lifespan Respite Care Program.

Client expense: $122,684 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

-H.R. 292/S. 849, support passage of the Advancing Research for Neurological Diseases Act. -H.R. 6, 21st Century Cures Act, support inclusion of H.R. 292/S. 849, support increased funding for the National Institutes of Health and support other provisions that speed the development of effective treatments for people with multiple sclerosis.

Client expense: $122,684 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

Support H.R. 292/S. 849 - Advancing Research for Neurological Diseases Act of 2015. Wrote a letter to CDC advocating for a Traumatic Brain Injury (TBI) survey. United Spinal signed onto Senate Health Education Labor and Pensions comment letter, facilitated by the HEALTH IT Now Coalition, of which United Spinal is a member, supporting expanded use of telehealth for individuals living with stroke and for expanded prediabetes education. United Spinal is actively engaged in ensuring improved access to, and education of, all prescription drugs including biologic pharmaceuticals (organic compounds used to treat individuals with MS, SCI etc.) and has requested additional meetings with personnel from the U.S. Food and Drug Administration. United Spinal supports S.849 - Advancing Research for Neurological Diseases Act of 2015. This bill will mandate that the Centers for Disease Control and Prevention track the incidence and prevalence of neurological diseases. United Spinal supports S. 800/H.R. 1631 - Enhancing the Stature and Visibility of Medical Rehabilitation Research at the NIH Act which better coordinates rehabilitation and disability research at the NIH. The Disability and Rehabilitation Research Coalition (DRRC), of which United Spinal is a member, offered comments in a letter to the Administration for Community Living, U.S. Department of Health and Human Services, on the proposed rule entitled, National Institute on Disability, Independent Living, and Rehabilitation Research. The proposed rule would implement the Workforce Innovation and Opportunity Act of 2014 which made significant changes to Title II (Research) of the Rehabilitation Act of 1973. It would also move NIDILRR from the Department of Education to the Department of Health and Human Services (Administration for Community Living). United Spinal submitted comments to the FDA Arthritis Advisory Committee meeting to raise concerns about a Remicade-luck drugs and the effects of ankylosing spondylitis.

S. 737/ H.R. 2253: Ensuring Access to Primary Care for Women & Children Act S. 849 / H.R. 292: The Advancing Research for Neurological Diseases Act S. 1465 / H.R. 2799: Furthering Access to Stroke Telemedicine (FAST) Act S. 2118: Ensuring Enhanced Access to Primary Care Act S. 2484/ H.R. 4442: CONNECT for Health Act; Section 303 H.R. 2948: Medicare Telehealth Parity Act of 2015, Section 105(a)(1) Preservation of the in-office ancillary exception to the Stark law; urging changes to the Meaningful Use Program.

Client expense: Not reported · Firm income: $260,000

Government targets: HOUSE OF REPRESENTATIVES, Medicare Payment Advisory Commission (MedPAC), SENATE

.R. 1020 STEM Education Act H.R. 1190/S. 141 Protecting Seniors' Access to Medicare Act H.R. 1314 Bipartisan Budget Act H.R. 160/S. 149 Protect Medical Innovation Act H.R. 1624/S. 1099, Protecting Affordable Coverage for Employees Act (PACE Act) H.R. 2061, Equitable Access to Care and Health (EACH) Act H.R. 2446 To amend title XIX of the Social Security Act to require the use of electronic visit verification for personal care services furnished under the Medicaid program, and for other purposes. H.R. 2603/S. 1475 Saving Lives, Saving Costs Act H.R. 2646 Helping Families in Mental Health Crisis Act H.R. 4212/S.704 Community Based Independence for Seniors Act H.R. 2745/S. 2102 Standard Mergers & Acquisitions Review Through Equal Rules (SMARTER) Act H.R. 2878/S. 1461 To provide for the extension of the enforcement instruction on supervision requirements for outpatient therapeutic services in critical access and small rural hospitals through 2015. H.R. 2911/S. 1697 Small Business Healthcare Relief Act H.R. 292/S. 2260 Long-Term Studies of Comprehensive Outcomes and Returns for the Economy Act (Long-Term SCORE Act) H.R. 3081/S. 1778 TELEmedicine for MEDicare (TELE-MED) Act H.R. 3539 Reinvigorating Antibiotic and Diagnostic Innovation (READI) Act H.R. 3660 Preventive Health Savings Act H.R. 3716 Ensuring Terminated Providers are Removed from Medicaid and CHIP Act H.R. 3762 Restoring Americans Healthcare Freedom Reconciliation Act H.R. 4469/S.2499 Health Savings Act of 2016 H.R. 4723 Protecting Taxpayers by Recovering Improper Obamacare Subsidy Overpayments Act H.R. 4725 Common Sense Savings Act H.R. 4732/S.2671 Advancing Medical Resident Training in Community Hospitals Act H.R. 4771 Help Efficient, Accessible, Low-cost, Timely Healthcare Act H.R. 4774 Training Tomorrows Doctors Today Act H.R. 4801 Medical Loss Ratio Accountability Act of 2016 H.R. 4832 Health Savings Protection Act H.R. 4848 Healthy Inpatient Procedures (HIP) Act H.R. 4878 Better Care, Lower Cost Act H.R. 5380 Telehealth Parity Act H.R. 6 21st Century Cures Act H.R.4442/S.2484 CONNECT for Health Act S. 1077 Advancing Breakthrough Medical Devices for Patients Act S. 1101 Medical Electronic Data Technology Enhancement for Consumers Health (MEDTECH) Act S. 139 Ensuring Access to Clinical Trials Act S. 1622 FDA Device Accountability Act S. 1945 Mental Health Reform Act of 2016 S. 2023 Prescription Drug Affordability Act S. 2030 Advancing Targeted Therapies for Rare Diseases Act S. 2045 Middle Class Health Benefits Tax Repeal Act S. 2075 American Worker Health Care Tax Relief Act S. 2153 Provider Payment Sunshine Act S. 2187 FDA Regulatory Efficiency Act S. 2343 Telehealth Innovation and Improvement Act S. 2511 Improving Health Information Technology Act S. 2680 Mental Health Reform Act of 2016 S. 2698 Preserving Consumer Health Accounts Act of 2016 S. 2713 Advancing Precision Medicine Act S. 754 Cybersecurity Information Sharing Act (CISA) S. 1101, the Medical Electronic Data Technology Enhancement for Consumers Health (MEDTECH) Act S. 1077, the Advancing Breakthrough Medical Devices for Patients Act. S. 1622, the FDA Device Accountability Act S. 2511, the Improving Health Information Technology Act S. 2680, the Mental Health Reform Act of 2016 S. 2713, the Advancing Precision Medicine Act

S. 737/ H.R. 2253: Ensuring Access to Primary Care for Women & Children Act S. 849 / H.R. 292: The Advancing Research for Neurological Diseases Act S. 1465 / H.R. 2799: Furthering Access to Stroke Telemedicine (FAST) Act S. 2118: A bill to amend title XIX of the Social Security Act to extend the application of the Medicare payment rate floor to primary care services furnished under Medicaid and to apply the rate floor to additional providers of primary care services. H.R. 2948: Medicare Telehealth Parity Act of 2015, Section 105(a)(1) Preservation of the in-office ancillary exception to the Stark law; urging changes to the Meaningful Use Program.

Client expense: $140,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Medicare Payment Advisory Commission (MedPAC), SENATE

S.141 / H.R. 1190: Protecting Seniors' Access to Medicare Act of 2015 S. 737/ H.R. 2253: Ensuring Access to Primary Care for Women & Children Act S. 849 / H.R. 292: The Advancing Research for Neurological Diseases Act S. 1465 / H.R. 2799: Furthering Access to Stroke Telemedicine (FAST) Act S. 2118: A bill to amend title XIX of the Social Security Act to extend the application of the Medicare payment rate floor to primary care services furnished under Medicaid and to apply the rate floor to additional providers of primary care services. H.R. 2948: Medicare Telehealth Parity Act of 2015, Section 105(a)(1) Preservation of the in-office ancillary exception to the Stark law; delay of Meaningful Use State 3.

Client expense: $170,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Medicare Payment Advisory Commission (MedPAC), SENATE

S. 141 / H.R. 1190: Protecting Seniors' Access to Medicare Act of 2015 S. 849 / H.R. 292: The Advancing Research for Neurological Diseases Act S. 857 / H.R. 1559 Health Outcomes, Planning, and Education (HOPE) for Alzheimers Act of 2015 S. 1465 / H.R. 2799: Furthering Access to Stroke Telemedicine (FAST) Act S. 737: Ensuring Access to Primary Care for Women & Children Act S. 1549: Care Planning Act H.R. 2: Medicare Access and CHIP Reauthorization Act of 2015, Title 1 and Section 523. Preservation of the in-office ancillary exception to the Stark law.

Client expense: $280,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Medicare Payment Advisory Commission (MedPAC), SENATE

S.141 / H.R. 1190: Protecting Seniors' Access to Medicare Act of 2015 S. 849 / H.R. 292: The Advancing Research for Neurological Diseases Act H.R. 2: Medicare Access and CHIP Reauthorization Act of 2015, Title 1 and Section 523. H.R. 270 - Flexibility in Health IT Reporting (Flex-IT) Act of 2015 H.R.639 - Improving Regulatory Transparency for New Medical Therapies Act S. 737: Ensuring Access to Primary Care for Women & Children Act Preservation of the in-office ancillary exception to the Stark law.

Client expense: $270,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Medicare Payment Advisory Commission (MedPAC), SENATE

Support H.R. 292/S. 849 - Advancing Research for Neurological Diseases Act of 2015 Amends the Public Health Service Act to require the Centers for Disease Control and Prevention to: (1) enhance and expand infrastructure and activities to track the epidemiology of neurological diseases, including multiple sclerosis and Parkinson's disease; and (2) incorporate information obtained through those activities into a National Neurological Diseases Surveillance System. Requires the Department of Health and Human Services (HHS) to ensure that the System facilitates further research on neurological diseases. Support HR 1969 Military and Veteran Caregiver Services Improvement Act. This bill expands eligibility for the family caregiver program of the Department of Veterans Affairs (VA) to include members of the Armed Forces or veterans who are seriously injured or who became ill on active duty prior to September 11, 2001. United Spinal submitted RFI comments as a member of the Disability and Rehabilitation Research Coalition as well as independently: "Inviting Comments and Suggestions on the Priorities specified for the NIH-wide Rehabilitation Research Plan". Support Lifespan Respite Reauthorization Act , HR 3913 and the Military and Veteran Caregiver Services Improvement Act (S. 1085 & HR 1969 - includes provisions to reauthorize the Lifespan Respite Care Program. Support S. 2141 - Transparent Ratings on Usability and Security to Transform Information Technology (TRUST IT) Act of 2015 - To amend the Public Health Service Act with respect to health information technology. Advocate for repeal of medical device tax. Submitted a comment letter to the FDA regarding the announcement of the establishment of their Patient Engagement Advisory Committee and stated our availability to help the FDA regarding patient preference information, benefit-risk determinations and clinical trial or registry design.

S. 737/ H.R. 2253: Ensuring Access to Primary Care for Women & Children Act S. 849 / H.R. 292: The Advancing Research for Neurological Diseases Act S. 1465 / H.R. 2799: Furthering Access to Stroke Telemedicine (FAST) Act S. 2118: A bill to amend title XIX of the Social Security Act to extend the application of the Medicare payment rate floor to primary care services furnished under Medicaid and to apply the rate floor to additional providers of primary care services. H.R. 2948: Medicare Telehealth Parity Act of 2015, Section 105(a)(1) Preservation of the in-office ancillary exception to the Stark law; urging changes to the Meaningful Use Program.

Client expense: Not reported · Firm income: $140,000

Government targets: HOUSE OF REPRESENTATIVES, Medicare Payment Advisory Commission (MedPAC), SENATE

"FY 2016 Labor, Health and Human Services, Education, and Related Agencies Appropriations," sections relating to the National Institutes of Health (NIH); "FY 2016 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations," all sections relating to the Food and Drug Administration; "FY 2016 Department of Defense Appropriations," all sections related to the Peer-Reviewed Neurotoxin Exposure Treatment Parkinson's Research (NETPR) program; "The Senate Innovations Initiative," issues related to funding for NIH and FDA, data collection, therapeutic incentives, patient engagement, telehealth, and clinical trials; "H.R. 292/S. 849, The Advancing Research for Neurological Diseases Act," all sections; Consolidated Omnibus Appropriations Act of 2015 (H.R. 2029)

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

-H.R. 292/S. 849, support passage of the Advancing Research for Neurological Diseases Act. -H.R. 6, 21st Century Cures Act, support inclusion of H.R. 292/S. 849, support increased funding for the National Institutes of Health and support other provisions that speed the development of effective treatments for people with multiple sclerosis.

Client expense: $70,307 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

-H.R. 292/S. 849, support passage of the Advancing Research for Neurological Diseases Act. -H.R. 6, 21st Century Cures Act, support inclusion of H.R. 292/S. 849, support increased funding for the National Institutes of Health and support other provisions that speed the development of effective treatments for people with multiple sclerosis. -H.R. 1516/S. 1013, support passage of the Ensuring Access to Quality Complex Rehabilitation Technology Act. -H.R. 3229/S. 2196, support passage to protect access to complex rehabilitative technology accessories. -S. 2425, Patient Access and Medicare Protection Act, support one-year delay of rule that would restrict access to complex rehabilitation technology accessories -H.R. 3913, Lifespan Respite Care Reauthorization Act, support reauthorization of the Lifespan Respite Care Program. -H.R. 1969, Military and Veteran Caregiver Services Improvement Act, support passage

Client expense: $70,307 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

H.R. 1190, Protecting Seniors' Access to Medicare Act of 2015 H.R. 1314, the Bipartisan Budget Act of 2015 H.R. 1427/S. 804 Medicare CGM Access Act H.R. 1624/S. 1099, the Protecting Affordable Coverage for Employees Act (PACE Act). H.R. 1686, the Preventing Diabetes in Medicare Act H.R. 1726/S. 1345, the Access to Quality Diabetes Education Act H.R. 2029, Consolidated Appropriations Act, 2016 H.R. 2050/S. 2045, the Middle Class Health Benefits Tax Repeal Act of 2015 H.R. 2061, the Equitable Access to Care and Health (EACH) Act H.R. 209/S. 139, the Ensuring Access to Clinical Trials Act H.R. 2102/S. 1131, the Medicare Diabetes Prevention Act H.R. 2205, the Data Security Act of 2015 H.R. 2404/S.1509, The Treat and Reduce Obesity Act H.R. 2446, To amend title XIX of the Social Security Act to require the use of electronic visit verification for personal care services furnished under the Medicaid program, and for other purposes. H.R. 2646, the Helping Families in Mental Health Crisis Act H.R. 2878/ S. 1461, to provide for the extension of the enforcement instruction on supervision requirements for outpatient therapeutic services in critical access and small rural hospitals through 2015. H.R. 2911/S. 1697, the Small Business Healthcare Relief Act H.R. 292/S. 2260, the Long-Term Studies of Comprehensive Outcomes and Returns for the Economy Act (Long-Term SCORE Act) H.R. 3081/S.1778 - TELEmedicine for MEDicare (TELE-MED) Act H.R. 3539, the Reinvigorating Antibiotic and Diagnostic Innovation (READI) Act H.R. 3660, the Preventive Health Savings Act H.R. 3716, the Ensuring Terminated Providers are Removed from Medicaid and CHIP Act H.R. 3762, the Restoring Americans Healthcare Freedom Reconciliation Act H.R. 3821, the Medicaid Directory of Caregivers Act H.R. 4155/S. 2343, the Telehealth Innovation and Improvement Act H.R. 4227/S.2392, the Medicare Advantage Bill of Rights Act H.R. 592/S. 314, Pharmacy and Medically Underserved Areas Enhancement Act H.R. 6, 21st Century Cures Act S. 139, Ensuring Access to Clinical Trials Act of 2015 S. 1945, Mental Health Reform Act of 2015 S. 2023, the Prescription Drug Affordability Act S. 2030, the Advancing Targeted Therapies for Rare Diseases Act S. 2104, A bill to amend title XVIII of the Social Security Act to provide relief to Medicare Advantage plans with a significant number of dually eligible or low-income subsidy beneficiaries and to prevent the termination of two star plans. S. 2141, TRUST IT Act S. 2153, the Provider Payment Sunshine Act, S. 2187, the FDA Regulatory Efficiency Act S. 2425, the Patient Access and Medicare Protection Act S. 754, the Cybersecurity Information Sharing Act (CISA)

Supports S.849 - Advancing Research for Neurological Diseases Act of 2015. This bill will mandate that the Centers for Disease Control and Prevention track the incidence and prevalence of neurological diseases. Also support the companion bill, HR 292 (which was included in the 21st Century Cures Initiative). United Spinal supports the Patient Access to Disposable Medical Technology Act of 2015, S.1253/H.R. 1018 - portable medical equipment that can be used outside of the hospital. United Spinal joined a coalition, led by the Center for Responsible Science, to file an FDA petition to broaden testing options in drug development and to update regulations that govern preclinical drug and device development. As a member of the Patients for Biologics Safety and Access, United Spinal is engaged in an advocacy campaign with Congress to ensure that Congress hold an oversight hearing with the Food and Drug Administration to ask for expedited publication of guidances on consumer safety and clinical testing for biological pharmaceuticals. A Senate HELP hearing with the FDA CDRH Director, Janet Woodcock testifying took place in September. United Spinal Association signed on to a letter spearheaded by the Advanced Medical Technology Association (AdvaMed) in support of repealing the tax on medical device manufacturers. Research shows that innovations in medical technology have greatly improved outcomes of individuals with disabilities. We are concerned that the medical device tax will curtail investments in future innovation, thereby reducing consumer access to innovative medicine and hampering their quality of life.

Client expense: Not reported · Firm income: $75,000

Supports S.849 - Advancing Research for Neurological Diseases Act of 2015. This bill will mandate that the Centers for Disease Control and Prevention track the incidence and prevalence of neurological diseases. Also support the companion bill, HR 292 (which was included in the 21st Century Cures Initiative). United Spinal supports the Patient Access to Disposable Medical Technology Act of 2015, S.1253/H.R. 1018 - portable medical equipment that can be used outside of the hospital. United Spinal joined a coalition, led by the Center for Responsible Science, to file an FDA petition to broaden testing options in drug development and to update regulations that govern preclinical drug and device development. As a member of the Patients for Biologics Safety and Access, United Spinal is engaged in an advocacy campaign with Congress to ensure that Congress hold an oversight hearing with the Food and Drug Administration to ask for expedited publication of guidances on consumer safety and clinical testing for biological pharmaceuticals. A Senate HELP hearing with the FDA CDRH Director, Janet Woodcock testifying took place in September. United Spinal Association signed on to a letter spearheaded by the Advanced Medical Technology Association (AdvaMed) in support of repealing the tax on medical device manufacturers. Research shows that innovations in medical technology have greatly improved outcomes of individuals with disabilities. We are concerned that the medical device tax will curtail investments in future innovation, thereby reducing consumer access to innovative medicine and hampering their quality of life.

Client expense: Not reported · Firm income: $75,000

Supports S.849 - Advancing Research for Neurological Diseases Act of 2015. This bill will mandate that the Centers for Disease Control and Prevention track the incidence and prevalence of neurological diseases. Also support the companion bill, HR 292 (which was included in the 21st Century Cures Initiative). United Spinal supports the Patient Access to Disposable Medical Technology Act of 2015, S.1253/H.R. 1018 - portable medical equipment that can be used outside of the hospital. United Spinal joined a coalition, led by the Center for Responsible Science, to file an FDA petition to broaden testing options in drug development and to update regulations that govern preclinical drug and device development. As a member of the Patients for Biologics Safety and Access, United Spinal is engaged in an advocacy campaign with Congress to ensure that Congress hold an oversight hearing with the Food and Drug Administration to ask for expedited publication of guidances on consumer safety and clinical testing for biological pharmaceuticals. A Senate HELP hearing with the FDA CDRH Director, Janet Woodcock testifying took place in September. United Spinal Association signed on to a letter spearheaded by the Advanced Medical Technology Association (AdvaMed) in support of repealing the tax on medical device manufacturers. Research shows that innovations in medical technology have greatly improved outcomes of individuals with disabilities. We are concerned that the medical device tax will curtail investments in future innovation, thereby reducing consumer access to innovative medicine and hampering their quality of life.

Client expense: Not reported · Firm income: $75,000

-H.R. 292/S. 849, support passage of the Advancing Research for Neurological Diseases Act. -H.R. 6, 21st Century Cures Act, support inclusion of H.R. 292/S. 849, support increased funding for the National Institutes of Health and support other provisions that speed the development of effective treatments for people with multiple sclerosis. -H.R. 1516/S. 1013, support passage of the Ensuring Access to Quality Complex Rehabilitation Technology Act. -H.R. 3229, support passage to protect access to complex rehabilitative technology accessories.

Client expense: $61,209 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

-H.R. 292/S. 849, support passage of the Advancing Research for Neurological Diseases Act. -H.R. 6, 21st Century Cures Act, support inclusion of H.R. 292/S. 849, support increased funding for the National Institutes of Health and support other provisions that speed the development of effective treatments for people with multiple sclerosis.

Client expense: $61,209 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

S.141 / H.R. 1190: Protecting Seniors' Access to Medicare Act of 2015 S. 737/ H.R. 2253: Ensuring Access to Primary Care for Women & Children Act S. 849 / H.R. 292: The Advancing Research for Neurological Diseases Act S. 1465 / H.R. 2799: Furthering Access to Stroke Telemedicine (FAST) Act S. 2118: A bill to amend title XIX of the Social Security Act to extend the application of the Medicare payment rate floor to primary care services furnished under Medicaid and to apply the rate floor to additional providers of primary care services. H.R. 2948: Medicare Telehealth Parity Act of 2015, Section 105(a)(1) Preservation of the in-office ancillary exception to the Stark law; delay of Meaningful Use State 3.

Client expense: Not reported · Firm income: $170,000

Government targets: HOUSE OF REPRESENTATIVES, Medicare Payment Advisory Commission (MedPAC), SENATE

"FY 2016 Labor, Health and Human Services, Education, and Related Agencies Appropriations," sections relating to the National Institutes of Health (NIH); "FY 2016 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations," all sections relating to the Food and Drug Administration; "FY 2016 Department of Defense Appropriations," all sections related to the Peer-Reviewed Neurotoxin Exposure Treatment Parkinson's Research (NETPR) program; "The 21st Century Cures Initiative," issues related to funding for NIH and FDA, data collection, therapeutic incentives, patient engagement, telehealth, and clinical trials; "H.R. 292/S. 849, The Advancing Research for Neurological Diseases Act," all sections;

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

"FY 2016 Labor, Health and Human Services, Education, and Related Agencies Appropriations," sections relating to the National Institutes of Health (NIH); "FY 2016 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations," all sections relating to the Food and Drug Administration; "FY 2016 Department of Defense Appropriations," all sections related to the Peer-Reviewed Neurotoxin Exposure Treatment Parkinson's Research (NETPR) program; "The 21st Century Cures Initiative," issues related to funding for NIH and FDA, data collection, therapeutic incentives, patient engagement, telehealth, and clinical trials; "H.R. 292/S. 849, The Advancing Research for Neurological Diseases Act," all sections; and the "FY 2016 National Defense Authorization Act," related to McCain Amendment SA 1482, to prohibit funding for certain medical research at the Department of Defense.

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 141 / H.R. 1190: Protecting Seniors' Access to Medicare Act of 2015 S. 849 / H.R. 292: The Advancing Research for Neurological Diseases Act S. 857 / H.R. 1559 Health Outcomes, Planning, and Education (HOPE) for Alzheimers Act of 2015 S. 1465 / H.R. 2799: Furthering Access to Stroke Telemedicine (FAST) Act S. 737: Ensuring Access to Primary Care for Women & Children Act S. 1549: Care Planning Act H.R. 2: Medicare Access and CHIP Reauthorization Act of 2015, Title 1 and Section 523. Preservation of the in-office ancillary exception to the Stark law.

Client expense: Not reported · Firm income: $280,000

Government targets: HOUSE OF REPRESENTATIVES, Medicare Payment Advisory Commission (MedPAC), SENATE

United Spinal Association calls for FDA Oversight and Congressional Hearings on Biologic Medicines Biologic medicines are made from living organisms and are far more complex and difficult to develop than traditional chemical drugs. United Spinal signed onto a Congressional letter to ask for support for the inclusion of $38 million in the FY 2016 Labor, Health and Human Services and Education Appropriations (LHHS) bill for the Assistive Technology (AT) Act Programs. Funding provided through the AT Act supports programs that assure people with disabilities have access to and acquisition of the assistive technology services they need to live, work, and attend school in their communities. United Spinal wrote a Congressional letter in support of The Enhancing the Stature and Visibility of Medical Rehabilitation Research at the NIH Act (companion bills: S. 800 and H.R. 1631) to improve, coordinate, and enhance medical rehabilitation research at the National Institutes of Health (NIH). Support HR 292, Advancing Research for Neurological Diseases Act of 2015, which amends the Public Health Service Act to require the Centers for Disease Control and Prevention to: (1) enhance and expand infrastructure and activities to track the epidemiology of neurological diseases, including multiple sclerosis and Parkinson's disease; and (2) incorporate information obtained through those activities into a National Neurological Diseases Surveillance System and requires the Department of Health and Human Services (HHS) to ensure that the System facilitates further research on neurological diseases. United Spinal signed on to a letter organized by the Autistic Self Advocacy Network to be sent to the Federal Drug Administration (FDA). The letter urged the FDA to act on the recommendations of the Neurological Devices Panel of the Medical Devices Advisory Committee that the harms of aversive conditioning devices used for contingent electric shock outweigh any potential benefits. The letter signatories called for the FDA to issue a total ban on any aversive conditioning devices used for contingent electric shock, in order to protect the publics right to safe, evidence-based treatment and the inherent human rights and dignity of people with disabilities. United Spinal Association signed onto an ARCH National Respite Network letter for House and Senate funding requests for FY2016 for the Labor/HHS/Education Appropriations bill for respite and other critical family support programs that provide a safety net for family caregivers across the lifespan and provides savings with proven prevention strategies. The letter requests $5.0 million for the Lifespan Respite Care Program, the amount included in the Presidents FY 2016 budget. We are also seeking support for the National Family Caregiver Support Program ($150 million), the Native American Caregiver Support Program ($6.8 million), and for the new Family Support program ($15 million) proposed by the President. United Spinal commended the United States House of Representatives Committee on Energy & Commerce Committee in support of the $10 billion NIH Innovation Fund which was added to a second discussion draft of the 21st Century Cures Act which makes improvements with access to medical devices, and prescription drugs. United Spinal policy staff requested members of Congress on the House and Senate Appropriations Committees to assist with United Spinal taking a leading role with an Administration for Community Living (ACL) federal $19,589,469 multi-year grant that funds a national Paralysis Resource Center (PRC) to provide access to the most comprehensive, high quality information and supports for people of all ages living with paralysis, their family and caregivers. United Spinal supports efforts by the American Academy of Pain Management and signed onto their letter to the Senate Finance Committee in implementing the development of a comprehensive population-level strategy to advance pain research, education, care and prevention, called the National Pain Strategy (NPS).

-H.R. 292/S. 849, support passage of the Advancing Research for Neurological Diseases Act. -H.R. 6, 21st Century Cures Act, support inclusion of H.R. 292/S. 849, support increased funding for the National Institutes of Health and support other provisions that speed the development of effective treatments for people with multiple sclerosis. -H.R. 1516/S. 1013, support passage of the Ensuring Access to Quality Complex Rehabilitation Technology Act.

Client expense: $95,695 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

-H.R. 292/S. 849, support passage of the Advancing Research for Neurological Diseases Act. -H.R. 6, 21st Century Cures Act, support inclusion of H.R. 292/S. 849, support increased funding for the National Institutes of Health and support other provisions that speed the development of effective treatments for people with multiple sclerosis.

Client expense: $95,695 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE